Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Micware Expands North American Presence with Relocation of U.S. Office in Dublin, Ohio
-
Trust Stamp announces presentation on Company’s progress and 2027 Business Plan
-
Propanc Biopharma Reports Preclinical Data with PRP & PRP plus TGF-β Inhibitor on TGF-β Pathway in Pancreatic Cancer
-
SkyAI Files Amended Tender Offer Documents and Reminds Security Holders To Tender Before the November 12, 2026 Expiration
-
IMUNON to Hold Third Quarter 2026 Financial Results and Business Update Conference Call on Thursday, November 12, 2026
-
Fluke Unveils Its Most Powerful Acoustic Imagers in a Smaller, Lighter Design, Enabling Faster Inspections and More Confident Maintenance Decisions
-
Galloway Capital Supports the PodcastOne Board’s Decision to Retain a Financial Advisor to Explore Strategic Alternatives
-
Lantheus Announces Presentation of Data at the 2026 Clinical Trials on Alzheimer’s Disease Annual Meeting
-
Privia Health Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP Business
-
TechForce Robotics Announces 60-Day Autonomous Robotics Pilot at Fairmont Austin
-
Disc Medicine to Participate in Upcoming Investor Conferences
-
Solomon Partners Continues Rapid Expansion With New West Palm Beach Office
-
Bicara Therapeutics to Report Third Quarter 2026 Financial Results and Business Updates on November 9, 2026, at 8:30 AM ET
-
Roze AI and BKB Energy Sign MOA to Evaluate AI Fire Forecasting System for AI Data Centers
-
Big Digital Energy to Participate in the Cantor Crypto and AI Infrastructure Conference
-
RESEARCH FRONTIERS TO HOST THIRD QUARTER 2026 CONFERENCE CALL
-
Schouw & Co. share buy-back programme, week 44 2026
-
newcleo Completes Acquisition of Bonifait Pesage, Bringing Nuclear-Grade Scales In-House
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
FrankCrum Staffing Expands into St. Petersburg with New Pinellas County Office
-
Bradbury Capital Inc. Announces Adjustment to Public Warrant Exercise Price Following Completion of $5 Million PIPE Financing
-
Deep Conduit Signature Identified Near Lawson 4 Expands Commercial Potential of Canada’s First Subsurface Natural Hydrogen System
-
Pathfinder Bancorp, Inc. Announces Financial Results for the Third Quarter of 2026
-
Inuvo’s IntentKey Puts Custom Audiences Live on Safari and iPhone Within 24 Hours
-
SmartPM Selected by Digital Realty to Standardize Construction Schedule Analytics Across Global Data Center Portfolio
-
TCT 2026 Clinical Data Reveals 84% Reporting Gap in Aortic Valve Calcification, Highlighting the Potential of Nanox.AI’s AVC Solution
-
LITE Shareholder Alert: Ademi LLP Investigates Whether Buyout Fairly Values Lumentum Holdings Inc.
-
Information on share capital and voting rights - October 2026
-
The Waqf Fund publishes first annual report, marking milestone in charitable investment
-
MARA Schedules Conference Call for Third Quarter 2026 Financial Results
-
Zomee Announces Industry-Leading Warranty Protection, Giving Moms More Confidence in Every Pump
-
Brixton Metals Announces Closing of First Tranche of Non-Brokered Private Placement
-
Sinai Health Foundation Puts Chronic Inflammation in the Spotlight
-
Edible Garden CEO Jim Kras to Discuss Innovation and Diversification at 2026 CEAg World Conference & Expo
-
Asure Software and Vertex Announce Strategic Alliance to Expand Payroll Tax Management Reach
-
Humacyte To Announce 2026 Third Quarter Financial Results and Provide Business Update on November 10, 2026
-
Fusemachines Launches New Video Series Showcasing Technology Maturity of HireFoundry.ai's Real-Time Interview Agent
-
New Adyen Data Reveals Canadian Small Businesses Risk Layoffs and Closures as Funding and Cash Flow Gaps Widen, New Adyen Data Shows
-
Radiopharm Theranostics Reports Business Update
-
Season’s Eatings: Tyson® Debuts New Holiday Nuggets
-
Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
-
Edible Garden CEO Jim Kras to Discuss Innovation and Diversification at 2026 CEAg World Conference & Expo
-
Fluence Strengthens Executive Leadership Team to Accelerate Operational Transformation
-
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer
-
NowVertical Announces Resignation of Director
-
Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response
-
New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation
-
Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets
-
Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.
-
CytomX Therapeutics to Present at Upcoming November Investor Conferences
